The GPI-anchoring of PrP

References

• Rudd PM, Merry AH, Wormald MR, Dwek RA. Glycosylation and prion protein. CurrOpinStructBiol 2002; 12:578 - 86; http://dx.doi.org/10.1016/S0959-440X(02)00377-9; PMID: 12464308
   PubMed Web of Science ®Google Scholar
• Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, Prusiner SB. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 1993; 32:1991 - 2002; http://dx.doi.org/10.1021/bi00059a016; PMID: 8448158
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. ProcNatlAcadSci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Fujita M, Kinoshita T. Structural remodeling of GPI anchors during biosynthesis and after attachment to proteins. FEBS Lett 2010; 584:1670 - 7; http://dx.doi.org/10.1016/j.febslet.2009.10.079; PMID: 19883648
   PubMed Web of Science ®Google Scholar
• FergusonMAJ, KinoshitaT, HartGW. Glycosylphosphatidylinositol Anchors. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2009. Chapter 11
   Google Scholar
• Paulick MG, Bertozzi CR. The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry 2008; 47:6991 - 7000; http://dx.doi.org/10.1021/bi8006324; PMID: 18557633
   PubMed Web of Science ®Google Scholar
• Orlean P, Menon AK. Thematic review series: lipid posttranslational modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids. J Lipid Res 2007; 48:993 - 1011; http://dx.doi.org/10.1194/jlr.R700002-JLR200; PMID: 17361015
   PubMed Web of Science ®Google Scholar
• Morandat S, Bortolato M, Roux B. Role of GPI-anchored enzyme in liposome detergent-resistance. J MembrBiol 2003; 191:215 - 21; http://dx.doi.org/10.1007/s00232-002-1056-y; PMID: 12571756
   PubMed Web of Science ®Google Scholar
• Barboni E, Rivero BP, George AJ, Martin SR, Renoup DV, Hounsell EF, Barber PC, Morris RJ. The glycophosphatidylinositol anchor affects the conformation of Thy-1 protein. J Cell Sci 1995; 108:487 - 97; PMID: 7539435
   PubMed Web of Science ®Google Scholar
• Kukulansky T, Abramovitch S, Hollander N. Cleavage of the glycosylphosphatidylinositol anchor affects the reactivity of thy-1 with antibodies. J Immunol 1999; 162:5993 - 7; PMID: 10229838
   PubMed Web of Science ®Google Scholar
• Legler DF, Doucey MA, Schneider P, Chapatte L, Bender FC, Bron C. Differential insertion of GPI-anchored GFPs into lipid rafts of live cells. FASEB J 2005; 19:73 - 5; PMID: 15516372
   PubMedGoogle Scholar
• Medof ME, Nagarajan S, Tykocinski ML. Cell-surface engineering with GPI-anchored proteins. FASEB J 1996; 10:574 - 86; PMID: 8621057
   PubMed Web of Science ®Google Scholar
• Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS, Gambetti P, Sy MS. Intercellular transfer of the cellular prion protein. J BiolChem 2002; 277:47671 - 8; http://dx.doi.org/10.1074/jbc.M207458200; PMID: 12359724
   PubMed Web of Science ®Google Scholar
• Vidugiriene J, Menon AK. The GPI anchor of cell-surface proteins is synthesized on the cytoplasmic face of the endoplasmic reticulum. J Cell Biol 1994; 127:333 - 41; http://dx.doi.org/10.1083/jcb.127.2.333; PMID: 7929579
   PubMed Web of Science ®Google Scholar
• Brewis IA, Ferguson MA, Mehlert A, Turner AJ, Hooper NM. Structures of the glycosyl-phosphatidylinositol anchors of porcine and human renal membrane dipeptidase. Comprehensive structural studies on the porcine anchor and interspecies comparison of the glycan core structures. J BiolChem 1995; 270:22946 - 56; http://dx.doi.org/10.1074/jbc.270.39.22946; PMID: 7559431
   PubMed Web of Science ®Google Scholar
• Meri S, Lehto T, Sutton CW, Tyynelä J, Baumann M. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis. Biochem J 1996; 316:923 - 35; PMID: 8670172
   PubMed Web of Science ®Google Scholar
• Stahl N, Baldwin MA, Burlingame AL, Prusiner SB. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 1990; 29:8879 - 84; http://dx.doi.org/10.1021/bi00490a001; PMID: 1980209
   PubMed Web of Science ®Google Scholar
• Baldwin MA. Analysis of glycosylphosphatidylinositol protein anchors: the prion protein. Methods Enzymol 2005; 405:172 - 87; http://dx.doi.org/10.1016/S0076-6879(05)05008-1; PMID: 16413315
   PubMed Web of Science ®Google Scholar
• Simons K, Sampaio JL. Membrane organization and lipid rafts. Cold Spring HarbPerspectBiol 2011; 3:a004697; http://dx.doi.org/10.1101/cshperspect.a004697; PMID: 21628426
   PubMed Web of Science ®Google Scholar
• Udenfriend S, Kodukula K. How glycosylphosphatidylinositol-anchored membrane proteins are made. Annu Rev Biochem 1995; 64:563 - 91; http://dx.doi.org/10.1146/annurev.bi.64.070195.003023; PMID: 7574493
   PubMed Web of Science ®Google Scholar
• Fujita M, Jigami Y. Lipid remodeling of GPI-anchored proteins and its function. BiochimBiophysActa 2008; 1780:410 - 20; http://dx.doi.org/10.1016/j.bbagen.2007.08.009; PMID: 17913366
   PubMed Web of Science ®Google Scholar
• Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010; 327:46 - 50; http://dx.doi.org/10.1126/science.1174621; PMID: 20044567
   PubMed Web of Science ®Google Scholar
• Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson EM Jr.. Lipid rafts in neuronal signaling and function. Trends Neurosci 2002; 25:412 - 7; http://dx.doi.org/10.1016/S0166-2236(02)02215-4; PMID: 12127758
   PubMed Web of Science ®Google Scholar
• Stefanová I, Horejsí V, Ansotegui IJ, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 1991; 254:1016 - 9; http://dx.doi.org/10.1126/science.1719635; PMID: 1719635
   PubMed Web of Science ®Google Scholar
• Chen Y, Veracini L, Benistant C, Jacobson K. The transmembrane protein CBP plays a role in transiently anchoring small clusters of Thy-1, a GPI-anchored protein, to the cytoskeleton. J Cell Sci 2009; 122:3966 - 72; http://dx.doi.org/10.1242/jcs.049346; PMID: 19825940
   PubMed Web of Science ®Google Scholar
• de Hoop MJ, Dotti CG. Membrane traffic in polarized neurons in culture. J Cell SciSuppl 1993; 17:85 - 92; http://dx.doi.org/10.1242/jcs.1993.Supplement_17.13; PMID: 8144707
   PubMedGoogle Scholar
• van Meer G, Simons K. Lipid polarity and sorting in epithelial cells. J Cell Biochem 1988; 36:51 - 8; http://dx.doi.org/10.1002/jcb.240360106; PMID: 3277985
   PubMed Web of Science ®Google Scholar
• Brown DA, Crise B, Rose JK. Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science 1989; 245:1499 - 501; http://dx.doi.org/10.1126/science.2571189; PMID: 2571189
   PubMed Web of Science ®Google Scholar
• Lisanti MP, Caras IW, Davitz MA, Rodriguez-Boulan E. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells. J Cell Biol 1989; 109:2145 - 56; http://dx.doi.org/10.1083/jcb.109.5.2145; PMID: 2478564
   PubMed Web of Science ®Google Scholar
• Sarnataro D, Paladino S, Campana V, Grassi J, Nitsch L, Zurzolo C. PrPC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts. Traffic 2002; 3:810 - 21; http://dx.doi.org/10.1034/j.1600-0854.2002.31106.x; PMID: 12383347
   PubMed Web of Science ®Google Scholar
• Paladino S, Sarnataro D, Pillich R, Tivodar S, Nitsch L, Zurzolo C. Protein oligomerization modulates raft partitioning and apical sorting of GPI-anchored proteins. J Cell Biol 2004; 167:699 - 709; http://dx.doi.org/10.1083/jcb.200407094; PMID: 15557121
   PubMed Web of Science ®Google Scholar
• Paladino S, Lebreton S, Tivodar S, Campana V, Tempre R, Zurzolo C. Different GPI-attachment signals affect the oligomerisation of GPI-anchored proteins and their apical sorting. J Cell Sci 2008; 121:4001 - 7; http://dx.doi.org/10.1242/jcs.036038; PMID: 19056670
   PubMed Web of Science ®Google Scholar
• Puig B, Altmeppen HC, Thurm D, Geissen M, Conrad C, Braulke T, Glatzel M. N-glycans and glycosylphosphatidylinositol-anchor act on polarized sorting of mouse PrP(C) in Madin-Darby canine kidney cells. PLoS One 2011; 6:e24624; http://dx.doi.org/10.1371/journal.pone.0024624; PMID: 21931781
   PubMedGoogle Scholar
• Madore N, Smith KL, Graham CH, Jen A, Brady K, Hall S, Morris R. Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J 1999; 18:6917 - 26; http://dx.doi.org/10.1093/emboj/18.24.6917; PMID: 10601014
   PubMed Web of Science ®Google Scholar
• Brügger B, Graham C, Leibrecht I, Mombelli E, Jen A, Wieland F, Morris R. The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition. J BiolChem 2004; 279:7530 - 6; http://dx.doi.org/10.1074/jbc.M310207200; PMID: 14660659
   PubMed Web of Science ®Google Scholar
• Tivodar S, Paladino S, Pillich R, Prinetti A, Chigorno V, van Meer G, Sonnino S, Zurzolo C. Analysis of detergent-resistant membranes associated with apical and basolateral GPI-anchored proteins in polarized epithelial cells. FEBS Lett 2006; 580:5705 - 12; http://dx.doi.org/10.1016/j.febslet.2006.09.022; PMID: 17007841
   PubMed Web of Science ®Google Scholar
• Mironov A Jr., Latawiec D, Wille H, Bouzamondo-Bernstein E, Legname G, Williamson RA, Burton D, DeArmond SJ, Prusiner SB, Peters PJ. Cytosolic prion protein in neurons. J Neurosci 2003; 23:7183 - 93; PMID: 12904479
   PubMed Web of Science ®Google Scholar
• Galvan C, Camoletto PG, Dotti CG, Aguzzi A, Ledesma MD. Proper axonal distribution of PrP(C) depends on cholesterol-sphingomyelin-enriched membrane domains and is developmentally regulated in hippocampal neurons. Mol Cell Neurosci 2005; 30:304 - 15; http://dx.doi.org/10.1016/j.mcn.2005.07.003; PMID: 16139509
   PubMed Web of Science ®Google Scholar
• Chen R, Knez JJ, Merrick WC, Medof ME. Comparative efficiencies of C-terminal signals of native glycophosphatidylinositol (GPI)-anchored proproteins in conferring GPI-anchoring. J Cell Biochem 2001; 84:68 - 83; http://dx.doi.org/10.1002/jcb.1267; PMID: 11746517
   PubMed Web of Science ®Google Scholar
• Nicholson TB, Stanners CP. Specific inhibition of GPI-anchored protein function by homing and self-association of specific GPI anchors. J Cell Biol 2006; 175:647 - 59; http://dx.doi.org/10.1083/jcb.200605001; PMID: 17101695
   PubMed Web of Science ®Google Scholar
• Nicholson TB, Stanners CP. Identification of a novel functional specificity signal within the GPI anchor signal sequence of carcinoembryonic antigen. J Cell Biol 2007; 177:211 - 8; http://dx.doi.org/10.1083/jcb.200701158; PMID: 17438079
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Hill AF, Beck JA, Collinge J. Molecular and clinical classification of human prion disease. Br Med Bull 2003; 66:241 - 54; http://dx.doi.org/10.1093/bmb/66.1.241; PMID: 14522862
   PubMed Web of Science ®Google Scholar
• Gu Y, Singh A, Bose S, Singh N. Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells. Mol Cell Neurosci 2008; 37:647 - 56; http://dx.doi.org/10.1016/j.mcn.2007.08.018; PMID: 18325785
   PubMed Web of Science ®Google Scholar
• Guizzunti G, Zurzolo C. The fate of PrP GPI-anchor signal peptide is modulated by P238S pathogenic mutation. Traffic 2014; 15:78 - 93; http://dx.doi.org/10.1111/tra.12126; PMID: 24112521
   PubMed Web of Science ®Google Scholar
• Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J BiolChem 1992; 267:16188 - 99; PMID: 1353761
   PubMed Web of Science ®Google Scholar
• Béranger F, Mangé A, Goud B, Lehmann S. Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells. J BiolChem 2002; 277:38972 - 7; http://dx.doi.org/10.1074/jbc.M205110200; PMID: 12163492
   PubMed Web of Science ®Google Scholar
• Marijanovic Z, Caputo A, Campana V, Zurzolo C. Identification of an intracellular site of prion conversion. PLoSPathog 2009; 5:e1000426; http://dx.doi.org/10.1371/journal.ppat.1000426; PMID: 19424437
   PubMedGoogle Scholar
• Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 2002; 21:1031 - 40; http://dx.doi.org/10.1093/emboj/21.5.1031; PMID: 11867531
   PubMed Web of Science ®Google Scholar
• Goold R, Rabbanian S, Sutton L, Andre R, Arora P, Moonga J, Clarke AR, Schiavo G, Jat P, Collinge J, et al. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun 2011; 2:281; http://dx.doi.org/10.1038/ncomms1282; PMID: 21505437
   PubMed Web of Science ®Google Scholar
• Goold R, McKinnon C, Rabbanian S, Collinge J, Schiavo G, Tabrizi SJ. Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane. J Cell Sci 2013; 126:3552 - 62; http://dx.doi.org/10.1242/jcs.120477; PMID: 23813960
   PubMed Web of Science ®Google Scholar
• Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129:121 - 32; http://dx.doi.org/10.1083/jcb.129.1.121; PMID: 7698979
   PubMed Web of Science ®Google Scholar
• Mangé A, Nishida N, Milhavet O, McMahon HE, Casanova D, Lehmann S. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol 2000; 74:3135 - 40; http://dx.doi.org/10.1128/JVI.74.7.3135-3140.2000; PMID: 10708429
   PubMed Web of Science ®Google Scholar
• Marella M, Lehmann S, Grassi J, Chabry J. Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J BiolChem 2002; 277:25457 - 64; http://dx.doi.org/10.1074/jbc.M203248200; PMID: 11994310
   PubMed Web of Science ®Google Scholar
• Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129:121 - 32; http://dx.doi.org/10.1083/jcb.129.1.121; PMID: 7698979
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471 - 4; http://dx.doi.org/10.1038/370471a0; PMID: 7913989
   PubMed Web of Science ®Google Scholar
• McNally KL, Ward AE, Priola SA. Cells expressing anchorless prion protein are resistant to scrapie infection. J Virol 2009; 83:4469 - 75; http://dx.doi.org/10.1128/JVI.02412-08; PMID: 19225008
   PubMed Web of Science ®Google Scholar
• Priola SA, McNally KL. The role of the prion protein membrane anchor in prion infection. Prion 2009; 3:134 - 8; http://dx.doi.org/10.4161/pri.3.3.9771; PMID: 19786843
   PubMed Web of Science ®Google Scholar
• Speare JO, Offerdahl DK, Hasenkrug A, Carmody AB, Baron GS. GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells. EMBO J 2010; 29:782 - 94; http://dx.doi.org/10.1038/emboj.2009.392; PMID: 20057357
   PubMed Web of Science ®Google Scholar
• Fernández-Borges N, Chianini F, Eraña H, Vidal E, Eaton SL, Pintado B, Finlayson J, Dagleish MP, Castilla J. Naturally prion resistant mammals: a utopia?. Prion 2012; 6:425 - 9; http://dx.doi.org/10.4161/pri.22057; PMID: 22954650
   PubMed Web of Science ®Google Scholar
• Nisbet RM, Harrison CF, Lawson VA, Masters CL, Cappai R, Hill AF. Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. J Virol 2010; 84:6678 - 86; http://dx.doi.org/10.1128/JVI.02709-09; PMID: 20427543
   PubMed Web of Science ®Google Scholar
• Jeffrey M, McGovern G, Sisó S, González L. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease. ActaNeuropathol 2011; 121:113 - 34; http://dx.doi.org/10.1007/s00401-010-0700-3; PMID: 20532540
   PubMed Web of Science ®Google Scholar
• Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339 - 47; http://dx.doi.org/10.1016/0092-8674(93)90360-3; PMID: 8100741
   PubMed Web of Science ®Google Scholar
• Mallucci G, Dickinson A, Linehan J, Klöhn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302:871 - 4; http://dx.doi.org/10.1126/science.1090187; PMID: 14593181
   PubMed Web of Science ®Google Scholar
• Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540 - 2; http://dx.doi.org/10.1038/nature09768; PMID: 21350487
   PubMed Web of Science ®Google Scholar
• Chesebro B, Race B, Meade-White K, Lacasse R, Race R, Klingeborn M, Striebel J, Dorward D, McGovern G, Jeffrey M. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoSPathog 2010; 6:e1000800; http://dx.doi.org/10.1371/journal.ppat.1000800; PMID: 20221436
   PubMedGoogle Scholar
• Fasano C, Campana V, Zurzolo C. Prions: protein only or something more? Overview of potential prion cofactors. J MolNeurosci 2006; 29:195 - 214; http://dx.doi.org/10.1385/JMN:29:3:195; PMID: 17085779
   PubMed Web of Science ®Google Scholar
• Taylor DR, Whitehouse IJ, Hooper NM. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoSPathog 2009; 5:e1000666; http://dx.doi.org/10.1371/journal.ppat.1000666; PMID: 19936054
   PubMedGoogle Scholar
• Fivaz M, Vilbois F, Thurnheer S, Pasquali C, Abrami L, Bickel PE, Parton RG, van der Goot FG. Differential sorting and fate of endocytosed GPI-anchored proteins. EMBO J 2002; 21:3989 - 4000; http://dx.doi.org/10.1093/emboj/cdf398; PMID: 12145200
   PubMed Web of Science ®Google Scholar
• Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, McCaffrey MW, Morris R. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 2003; 22:3591 - 601; http://dx.doi.org/10.1093/emboj/cdg344; PMID: 12853474
   PubMed Web of Science ®Google Scholar
• Taylor DR, Hooper NM. The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem J 2007; 402:17 - 23; http://dx.doi.org/10.1042/BJ20061736; PMID: 17155929
   PubMed Web of Science ®Google Scholar
• Parkyn CJ, Vermeulen EG, Mootoosamy RC, Sunyach C, Jacobsen C, Oxvig C, Moestrup S, Liu Q, Bu G, Jen A, et al. LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J Cell Sci 2008; 121:773 - 83; http://dx.doi.org/10.1242/jcs.021816; PMID: 18285446
   PubMed Web of Science ®Google Scholar
• Sarnataro D, Caputo A, Casanova P, Puri C, Paladino S, Tivodar SS, Campana V, Tacchetti C, Zurzolo C. Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells. PLoS One 2009; 4:e5829; http://dx.doi.org/10.1371/journal.pone.0005829; PMID: 19503793
   PubMedGoogle Scholar
• Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673 - 728; http://dx.doi.org/10.1152/physrev.00007.2007; PMID: 18391177
   PubMed Web of Science ®Google Scholar
• Biasini E, Turnbaugh JA, Unterberger U, Harris DA. Prion protein at the crossroads of physiology and disease. Trends Neurosci 2012; 35:92 - 103; http://dx.doi.org/10.1016/j.tins.2011.10.002; PMID: 22137337
   PubMed Web of Science ®Google Scholar
• Bate C, Williams A. Role of glycosylphosphatidylinositols in the activation of phospholipase A2 and the neurotoxicity of prions. J Gen Virol 2004; 85:3797 - 804; http://dx.doi.org/10.1099/vir.0.80366-0; PMID: 15557253
   PubMed Web of Science ®Google Scholar
• Bate C, Tayebi M, Williams A. Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration. MolNeurodegener 2010; 5:13; http://dx.doi.org/10.1186/1750-1326-5-13; PMID: 20374666
   PubMedGoogle Scholar
• Brown WJ, Chambers K, Doody A. Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic 2003; 4:214 - 21; http://dx.doi.org/10.1034/j.1600-0854.2003.00078.x; PMID: 12694560
   PubMed Web of Science ®Google Scholar
• Bate C, Williams A. Neurodegeneration induced by clustering of sialylatedglycosylphosphatidylinositols of prion proteins. J BiolChem 2012; 287:7935 - 44; http://dx.doi.org/10.1074/jbc.M111.275743; PMID: 22262833
   PubMed Web of Science ®Google Scholar
• Bate C, Williams A. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation. J BiolChem 2011; 286:8752 - 8; http://dx.doi.org/10.1074/jbc.M110.186833; PMID: 21212283
   PubMed Web of Science ®Google Scholar
• Bate C, Williams A. The cellular prion protein with a monoacylatedglycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation. Prion 2011; 5:65 - 8; http://dx.doi.org/10.4161/pri.5.2.16095; PMID: 21738009
   PubMed Web of Science ®Google Scholar
• Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008; 181:551 - 65; http://dx.doi.org/10.1083/jcb.200711002; PMID: 18443219
   PubMed Web of Science ®Google Scholar
• Wang YT, Salter MW. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 1994; 369:233 - 5; http://dx.doi.org/10.1038/369233a0; PMID: 7514272
   PubMed Web of Science ®Google Scholar
• Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 2004; 5:317 - 28; http://dx.doi.org/10.1038/nrn1368; PMID: 15034556
   PubMed Web of Science ®Google Scholar
• Swanwick CC, Shapiro ME, Yi Z, Chang K, Wenthold RJ. NMDA receptors interact with flotillin-1 and -2, lipid raft-associated proteins. FEBS Lett 2009; 583:1226 - 30; http://dx.doi.org/10.1016/j.febslet.2009.03.017; PMID: 19298817
   PubMed Web of Science ®Google Scholar
• Ponce J, de la Ossa NP, Hurtado O, Millan M, Arenillas JF, Dávalos A, Gasull T. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection. Stroke 2008; 39:1269 - 75; http://dx.doi.org/10.1161/STROKEAHA.107.498923; PMID: 18323503
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289:1925 - 8; http://dx.doi.org/10.1126/science.289.5486.1925; PMID: 10988071
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 2012; 15:1227 - 35; http://dx.doi.org/10.1038/nn.3178; PMID: 22820466
   PubMed Web of Science ®Google Scholar
• Um JW, Strittmatter SM. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion 2013; 7:37 - 41; http://dx.doi.org/10.4161/pri.22212; PMID: 22987042
   PubMed Web of Science ®Google Scholar
• Larson ME, Lesné SE. Soluble Aβ oligomer production and toxicity. J Neurochem 2012; 120:Suppl 1 125 - 39; http://dx.doi.org/10.1111/j.1471-4159.2011.07478.x; PMID: 22121920
   PubMed Web of Science ®Google Scholar
• Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, et al. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication. EMBO J 2011; 30:2057 - 70; http://dx.doi.org/10.1038/emboj.2011.86; PMID: 21441896
   PubMed Web of Science ®Google Scholar
• Pradines E, Hernandez-Rapp J, Villa-Diaz A, Dakowski C, Ardila-Osorio H, Haik S, Schneider B, Launay JM, Kellermann O, Torres JM, et al. Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance. Cell Death Dis 2013; 4:e456; http://dx.doi.org/10.1038/cddis.2012.195; PMID: 23303130
   PubMedGoogle Scholar
• Rambold AS, Müller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J. Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J 2008; 27:1974 - 84; http://dx.doi.org/10.1038/emboj.2008.122; PMID: 18566584
   PubMed Web of Science ®Google Scholar
• Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases. J BiolChem 1995; 270:19173 - 80; http://dx.doi.org/10.1074/jbc.270.32.19173; PMID: 7642585
   PubMed Web of Science ®Google Scholar
• Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, Hooper NM. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J BiolChem 2009; 284:22590 - 600; http://dx.doi.org/10.1074/jbc.M109.032599; PMID: 19564338
   PubMed Web of Science ®Google Scholar
• Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, Jorissen E, Petrowitz B, Bartsch U, De Strooper B, et al. Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. MolNeurodegener 2011; 6:36; http://dx.doi.org/10.1186/1750-1326-6-36; PMID: 21619641
   PubMedGoogle Scholar
• Sunyach C, Cisse MA, da Costa CA, Vincent B, Checler F. The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J BiolChem 2007; 282:1956 - 63; http://dx.doi.org/10.1074/jbc.M609663200; PMID: 17121821
   PubMed Web of Science ®Google Scholar
• Westergard L, Turnbaugh JA, Harris DA. A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J BiolChem 2011; 286:44234 - 42; http://dx.doi.org/10.1074/jbc.M111.286195; PMID: 22025612
   PubMed Web of Science ®Google Scholar
• Altmeppen HC, Prox J, Puig B, Dohler F, Falker C, Krasemann S, Glatzel M. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration. FEBS J 2013; 280:4338 - 47; http://dx.doi.org/10.1111/febs.12196; PMID: 23413979
   PubMed Web of Science ®Google Scholar
• Meier P, Genoud N, Prinz M, Maissen M, Rülicke T, Zurbriggen A, Raeber AJ, Aguzzi A. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell 2003; 113:49 - 60; http://dx.doi.org/10.1016/S0092-8674(03)00201-0; PMID: 12679034
   PubMed Web of Science ®Google Scholar
• Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S, Checler F. The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J BiolChem 2009; 284:35973 - 86; http://dx.doi.org/10.1074/jbc.M109.051086; PMID: 19850936
   PubMed Web of Science ®Google Scholar
• Guillot-Sestier MV, Checler F. α-Secretase-derived cleavage of cellular prion yields biologically active catabolites with distinct functions. Neurodegener Dis 2012; 10:294 - 7; http://dx.doi.org/10.1159/000333804; PMID: 22261541
   PubMed Web of Science ®Google Scholar
• Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, Mansuy IM, Aguzzi A. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2010; 2:306 - 14; http://dx.doi.org/10.1002/emmm.201000082; PMID: 20665634
   PubMed Web of Science ®Google Scholar
• Béland M, Motard J, Barbarin A, Roucou X. PrP(C) homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1. J Neurosci 2012; 32:13255 - 63; http://dx.doi.org/10.1523/JNEUROSCI.2236-12.2012; PMID: 22993441
   PubMed Web of Science ®Google Scholar
• Nieznanski K, Choi JK, Chen S, Surewicz K, Surewicz WK. Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity. J BiolChem 2012; 287:33104 - 8; http://dx.doi.org/10.1074/jbc.C112.400614; PMID: 22915585
   PubMed Web of Science ®Google Scholar
• Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C, La Vitola P, Messa M, Colombo L, Forloni G, et al. An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo. J BiolChem 2013; 288:7857 - 66; http://dx.doi.org/10.1074/jbc.M112.423954; PMID: 23362282
   PubMed Web of Science ®Google Scholar
• Ostapchenko VG, Beraldo FH, Guimarães AL, Mishra S, Guzman M, Fan J, Martins VR, Prado VF, Prado MA. Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer’s disease. J Neurochem 2013; 127:415 - 25; http://dx.doi.org/10.1111/jnc.12296; PMID: 23651058
   PubMed Web of Science ®Google Scholar
• Altmeppen HC, Puig B, Dohler F, Thurm DK, Falker C, Krasemann S, Glatzel M. Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis 2012; 1:15 - 31; PMID: 23383379
   PubMedGoogle Scholar
• Liang J, Kong Q. α-Cleavage of cellular prion protein. Prion 2012; 6:453 - 60; http://dx.doi.org/10.4161/pri.22511; PMID: 23052041
   PubMed Web of Science ®Google Scholar
• McDonald AJ, Dibble JP, Evans EG, Millhauser GL. A New Paradigm for Enzymatic Control of α-Cleavage and β-Cleavage of the Prion Protein. J BiolChem 2014; 289:803 - 13; http://dx.doi.org/10.1074/jbc.M113.502351; PMID: 24247244
   PubMed Web of Science ®Google Scholar
• Wik L, Klingeborn M, Willander H, Linne T. Separate mechanisms act concurrently to shed and release the prion protein from the cell. Prion 2012; 6:498 - 509; http://dx.doi.org/10.4161/pri.22588; PMID: 23093798
   PubMed Web of Science ®Google Scholar
• Walmsley AR, Watt NT, Taylor DR, Perera WS, Hooper NM. alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol Cell Neurosci 2009; 40:242 - 8; http://dx.doi.org/10.1016/j.mcn.2008.10.012; PMID: 19056496
   PubMed Web of Science ®Google Scholar
• Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA, Kong Q. Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle. J BiolChem 2012; 287:16510 - 20; http://dx.doi.org/10.1074/jbc.M112.360891; PMID: 22447932
   PubMed Web of Science ®Google Scholar
• Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. ProcNatlAcadSci U S A 2001; 98:5815 - 20; http://dx.doi.org/10.1073/pnas.081612998; PMID: 11309494
   PubMed Web of Science ®Google Scholar
• Kojro E, Füger P, Prinzen C, Kanarek AM, Rat D, Endres K, Fahrenholz F, Postina R. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis. J Alzheimers Dis 2010; 20:1215 - 31; PMID: 20413873
   PubMed Web of Science ®Google Scholar
• Harris B, Pereira I, Parkin E. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Brain Res 2009; 1296:203 - 15; http://dx.doi.org/10.1016/j.brainres.2009.07.105; PMID: 19679113
   PubMed Web of Science ®Google Scholar
• Murai T, Maruyama Y, Mio K, Nishiyama H, Suga M, Sato C. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J BiolChem 2011; 286:1999 - 2007; http://dx.doi.org/10.1074/jbc.M110.184010; PMID: 21087933
   PubMed Web of Science ®Google Scholar
• Rushworth JV, Griffiths HH, Watt NT, Hooper NM. Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1. J BiolChem 2013; 288:8935 - 51; http://dx.doi.org/10.1074/jbc.M112.400358; PMID: 23386614
   PubMed Web of Science ®Google Scholar
• Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A, Wisniewski T, Koleske AJ, et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron 2013; 79:887 - 902; http://dx.doi.org/10.1016/j.neuron.2013.06.036; PMID: 24012003
   PubMed Web of Science ®Google Scholar